certolizumab pegol

noun

cer·​to·​liz·​u·​mab peg·​ol ˌsər-tə-ˈliz-yü-ˌmab-ˈpeg-ˌȯl 

: a monoclonal antibody fragment that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat Crohn's disease, rheumatoid arthritis, psoriatic arthritis, and ankylosing arthritis

Note: Certolizumab pegol is marketed under the trademark Cimzia.